The week in health tech, explained in plain English.Get the free newsletter →
October 30, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

CMS Tightens Oversight of Hospital Accrediting Bodies

CMS finalized a rule on June 12 to sharpen its oversight of the nine accrediting organizations that survey more than 9,000 healthcare organizations each year for compliance with federal health and safety requirements, Becker's Hospital Review reports. Bodies like The Joint Commission act as gatekeepers to Medicare participation, so their judgments carry enormous weight over which hospitals and providers can bill the program.

The rule zeroes in on conflicts of interest. CMS flagged arrangements where accrediting organizations sell consulting services to the same providers they later survey, and cases where accredited providers keep their status even after problems surface. The agency framed the move with a classic question: who watches the watchmen?

In practice, accrediting bodies will face stricter federal scrutiny of how they conduct surveys and manage potential conflicts. For hospitals, that could mean tougher, more consistent reviews and less room to lean on advisory relationships with their accreditor. The broader aim is to make accreditation a more reliable proxy for patient safety and regulatory compliance.

More in Government

Government

Medicare Rule Could Cut Remote Patient Monitoring Access

A proposed CMS rule could sharply reduce Medicare reimbursement for remote patient monitoring, threatening access for rural and chronically ill patients.

Why it matters: Remote monitoring has become a fast-growing, loosely overseen Medicare service, and changing how it pays could reshape home-based care for millions.

Government

HHS Launches National Plan to Overhaul US Kidney Care

HHS launched a national kidney care plan centered on prevention, dialysis reform with more patient choice, and overhauling the transplant system.

Why it matters: Kidney disease affects 1 in 7 US adults and drives major Medicare spending, so federal direction here reshapes care models and markets.

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.